News & AnalysisDay Zero Diagnostics snags $21mDay Zero Diagnostics, Inc., an infectious disease diagnostics company, has raised $21 million in funding.ByIris Dorbian9 February 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs